1. Home
  2. About Us
  3. Company Profile
  4. Company Outline

Company Outline

Company Name Olympus Corporation
Market Tokyo Stock Exchange
Stock Code ISIN: JP3201200007
Established October 12, 1919
Director, Representative Executive Officer, President and CEO Yasuo Takeuchi
Head Office Shinjuku Monolith, 3-1 Nishi-Shinjuku 2-chome, Shinjuku-ku, Tokyo 163-0914, Japan

Map
Business Lines Manufacture and sales of precision machineries and instruments
Share Capital 124.60 billion yen (As of March 31, 2022)
Consolidated Revenue 868.9 billion yen (Fiscal year ended March 31, 2022)
Consolidated Headcount 31,557 (As of March 31, 2022)

Share of Revenue by Business Segment

Fiscal year ended March 2022: Consolidated revenue 868.9 billion Yen. Share of revenue by business segment: Endoscopic Solutions 461.5 billion Yen 53.1%, Therapeutic Solutions 275.6 billion Yen 31.7%, Scientific Solutions 119.1 billion Yen 13.7%, and Other 12.6 billion Yen 1.5%.

Our largest business domain is medical solutions business.
Medical business consist of Endoscopic Solutions and Therapeutic Solutions. They cover nearly 85% of the revenue. Especially, Endoscopic Solutions occupies the largest part.

See Olympus Medical Business for details opens in new window

Number of Group Companies

108 (Excluding Olympus Corporation)

Revenue and Operating Profit

Revenue and operating profit, fiscal year ended March:2018 Revenue 786.5 billion Yen, operating profit 81 billion Yen, 2019 Revenue 793.9 billion Yen, operating profit 28.3 billion Yen, 2020 Revenue 755.2 billion Yen, operating profit 92.2 billion Yen, 2021 Revenue 730.5 billion Yen, operating profit 80.2 billion Yen, 2022 Revenue 868.9 billion Yen, operating profit 153.9 billion Yen.

Note) We split off the imaging business to a special purpose company established by Japan Industrial Partners, Inc. on January 1, 2021. In this regard, imaging division is categorized as a discontinued operation, effective Q2 of FY2021 and figures of FY2020 is restated.

Revenue by Region (Unit: Billions of Yen)

Fiscal year ended March 2022: Consolidated revenue 868.9 billion Yen. Japan 135.2 billion Yen 16%, North America 293.4 billion Yen 34%, Europe 217.9 billion Yen 25%, China 125.4 billion Yen 14%, Asia and Oceania 77.5 billion Yen 9%, Other Region 19.5 billion Yen 2%.Fiscal year ended March 2022: Consolidated revenue 868.9 billion Yen. Japan 135.2 billion Yen 16%, North America 293.4 billion Yen 34%, Europe 217.9 billion Yen 25%, China 125.4 billion Yen 14%, Asia and Oceania 77.5 billion Yen 9%, Other Region 19.5 billion Yen 2%.